Literature DB >> 11691784

Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability.

A Menoyo1, H Alazzouzi, E Espín, M Armengol, H Yamamoto, S Schwartz.   

Abstract

Maintenance of genomic stability depends on the appropriate cellular responses to DNA damage and the integrity of the DNA repair systems. We analyzed stomach tumors with microsatellite instability (MSI) for frameshift mutations in several potential targets of the mutator phenotype involved in DNA damage-response pathways, such as the ataxia telangiectasia mutated protein-related protein (ATR)-CHK1-Cdc25c pathway, and DNA repair. High frequency of mutations was found within ATR [5 (21%) of 23], MED1 [10 (43%) of 23], hMSH3 [13 (56%) of 23], and hMSH6 [10 (43%) of 23] genes. Also, a low frequency of mutations within the CHK1 gene was detected in 9% (2 of 23) of tumors. No mutations of hMLH3, ATM, BRCA1, or NBS1 genes were detected. These results confirm ATR, MED1, and CHK1 as targets of the mutator pathway in stomach tumorigenesis, and also suggest a potential role of MED1 increasing, together with hMSH3 and hMSH6, the genomic instability in the mutator pathway as a secondary mutator. Furthermore, these results suggest that the inhibition of the ATR-CHK1 DNA damage-response pathway might be involved in the tumorigenesis of gastric cancer with microsatellite instability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11691784

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  59 in total

1.  Genome maintenance defects in cultured cells and mice following partial inactivation of the essential cell cycle checkpoint gene Hus1.

Authors:  Peter S Levitt; Min Zhu; Amy Cassano; Stephanie A Yazinski; Houchun Liu; Joshua Darfler; Rachel M Peters; Robert S Weiss
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

2.  Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner.

Authors:  Oren Gilad; Barzin Y Nabet; Ryan L Ragland; David W Schoppy; Kevin D Smith; Amy C Durham; Eric J Brown
Journal:  Cancer Res       Date:  2010-11-23       Impact factor: 12.701

3.  Cross-talk between Chk1 and Chk2 in double-mutant thymocytes.

Authors:  Kathrin Zaugg; Yu-Wen Su; Patrick T Reilly; Yasmin Moolani; Carol C Cheung; Razquallah Hakem; Atsushi Hirao; Qinghua Liu; Stephen J Elledge; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-26       Impact factor: 11.205

4.  ATR and H2AX cooperate in maintaining genome stability under replication stress.

Authors:  Rebecca A Chanoux; Bu Yin; Karen A Urtishak; Amma Asare; Craig H Bassing; Eric J Brown
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

5.  Ataxia telangiectasia and rad3-related kinase contributes to cell cycle arrest and survival after cisplatin but not oxaliplatin.

Authors:  Kriste A Lewis; Kia K Lilly; Evelyn A Reynolds; William P Sullivan; Scott H Kaufmann; William A Cliby
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

6.  Is activation of the intra-S checkpoint in human fibroblasts an important factor in protection against UV-induced mutagenesis?

Authors:  Christopher D Sproul; Shangbang Rao; Joseph G Ibrahim; William K Kaufmann; Marila Cordeiro-Stone
Journal:  Cell Cycle       Date:  2013-09-25       Impact factor: 4.534

Review 7.  Cell cycle kinases as therapeutic targets for cancer.

Authors:  Silvia Lapenna; Antonio Giordano
Journal:  Nat Rev Drug Discov       Date:  2009-07       Impact factor: 84.694

Review 8.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

9.  Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis.

Authors:  Weinong Han; Keyoumars Soltani; Mei Ming; Yu-Ying He
Journal:  Cancer Prev Res (Phila)       Date:  2012-07-30

Review 10.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.